Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. and SD R&D patent PDE2 inhibitors

Dec. 22, 2016

Jiangsu Tasly Diyi Pharmaceutical presents antiviral agents

Dec. 21, 2016

Teijin Pharma develops CDK4/cyclin D3 and CDK6/cyclin D3 inhibitors

Dec. 21, 2016

Rugen Holdings describes NR2B receptor antagonists

Dec. 21, 2016

Sunshine Lake Pharma discloses 5-HT reuptake inhibitors and/or 5-HT1A receptor agonists

Dec. 21, 2016

GlaxoSmithKline patents KMO inhibitors

Dec. 21, 2016

Owen-Barry Pharmaceuticals presents sodium channel blockers

Dec. 20, 2016

Presage Biosciences develops autophagy inhibitors

Dec. 20, 2016

Qingdao Marine Biomedical Research Institute describes agents for cancer

Dec. 20, 2016

Yeungnam University discloses agents for inflammatory bowel disease

Dec. 20, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...